Impel NeuroPharma makes progress with intranasal delivery system; FDA warns against jet injector use for flu shots;

> Impel NeuroPharma has provided an update on its intranasal system for delivering drugs in to the brain, saying that it now has two funded collaborations with "top-10" drugmakers and has raised more than $500,000 in equity investments from angel investors. Release

> Two chemists at Syracuse University showed off their research of chemo-laden gold nanoparticles as the NCI pumps $30 million per year into nanotechnology for cancer treatment and diagnosis. Article

> On the heels of a $35 million Series A round of funding last week, Sage Therapeutics announced its license to Captisol technology from Ligand Pharmaceuticals ($LGND). Release

> The FDA has warned clinics not to use jet injector systems to give people flu vaccines, as the devices have not been approved for administering flu shots. Story

> Medimetrics Personalized Drug Delivery has found a partner to use its IntelliCap system as a clinical research tool. Item

> In a new collaboration between the two U.K. firms, Encap Drug Delivery will combine its liquid-filled capsule knowhow with Lena Nanoceutics nanoparticle engineering tech to develop new delivery capabilities. Release

> The FDA approved Watson Pharmaceuticals' ($WPI) testosterone transdermal patch, which the Parsippany, NJ-based firm plans to begin selling next month for conditions that require testosterone therapy. Announcement

> Halozyme Therapeutics ($HALO) has succeeded in two mid-stage studies of its ultrafast PH20 insulin analog formulations for treating patients with type 1 and type 2 diabetes. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.